Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis.
Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis. — المؤلف: Kessler, Brittelle E — Oncogene 20190429
- المؤلف
- Kessler, Brittelle E
- النشر
- Oncogene 20190429
- الوصف
- 2565-2579 p.
- الموضوعات
- Apoptosis؛ Cell Line, Tumor؛ Crk-Associated Substrate Protein؛ Dasatinib؛ Drug Resistance, Neoplasm؛ Focal Adhesion Kinase 1؛ Humans؛ Mutation